Introducing Panalgo, formerly BHE.
Read Our StorySee what’s new with Panalgo, formerly BHE, and around the industry.
Panalgo’s IHD software to be used by the EMA to rapidly answer questions around drug safety and efficacy and better understand real-world medication use.
Panalgo’s new Data Science module seamlessly integrates machine-learning techniques to identify new insights for patient care
Panalgo, which conveys “an algorithm for everything,” aligns with company vision of streamlining analytics, enabling pharma, payers, and providers to make more impactful decisions
BHE, a leading healthcare analytics company, has announced the formation of its Strategic Advisory Board. The initial appointments include Peter Neumann, ScD, Director of the Center for the Evaluation of Value and Risk in Health at Tufts Medical Center, and Samy Suissa, PhD, Distinguished James McGill Professor at McGill University. The Strategic Advisory Board will […]
Boston Health Economics (BHE), a leading healthcare self-service analytics company, and Premier Healthcare Solutions, Inc. (Premier), a leading healthcare improvement company, are joining forces to streamline data analytics and more quickly uncover strategies that could improve patient care. Through the partnership, Premier Applied Sciences, the research division of Premier, will offer its gold-standard Premier Healthcare […]
A consortium of leading healthcare companies today announced the launch of the COVID-19 Research Database, a secure repository of HIPAA-compliant, de-identified and limited patient-level data sets made available to public health and policy researchers to extract insights to help combat the COVID-19 pandemic. The database is a pro bono, cross-industry collaboration. Collaborators include Advarra, Aetion, […]
BHE, an innovative healthcare analytics company, today announced a $78 million minority growth investment led by Silversmith Capital Partners (“Silversmith”) and Leerink Transformation Partners (“LTP”). The new funding will accelerate the development and market expansion of BHE’s flagship Instant Health Data (IHD) platform, the market-leading real-world evidence (RWE) analytics solution currently being used by over […]
BHE is pleased to announce a new partnership with OM1 that facilitates the direct licensing of, and access to, OM1’s Disease Registry Databases via BHE’s market-leading real-world evidence (RWE) platform, Instant Health Data (IHD). OM1 maintains clinically rich longitudinal data in several chronic disease areas, including immunology. OM1’s Rheumatoid Arthritis (RA) Registry Database is among […]
Put reliable, rapid analytics in the hands of more people across your organization
